P F Bruning
Overview
Explore the profile of P F Bruning including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
904
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Ridder C, Zonderland M, Thijssen J, Bruning P, Barth A, Steenbruggen A, et al.
Am J Hum Biol
. 2017 May;
5(3):251-257.
PMID: 28548412
Plasma levels of gonadotropins, (sex) steroids, SHBG bound fractions of 17β-estradiol (E2) and testosterone (T), and sex-hormone-binding globulin (SHBG) were compared at the onset of puberty in female gymnasts (n...
2.
Toniolo P, Bruning P, Akhmedkhanov A, Bonfrer J, Koenig K, Lukanova A, et al.
Int J Cancer
. 2000 Nov;
88(5):828-32.
PMID: 11072255
Insulin-like growth factor I (IGF-I) is a systemic hormone with potent mitogenic and anti-apoptotic properties, which could influence the proliferative behavior of normal breast cells. Limited epidemiological observations suggest that...
3.
Kramer J, Curran D, Piccart M, de Haes J, Bruning P, Klijn J, et al.
Eur J Cancer
. 2000 Aug;
36(12):1488-97.
PMID: 10930796
The aim of the study was to compare the quality of life (QL) of patients treated with single-agent paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer. 331 patients...
4.
Boogerd W, Dorresteijn L, van der Sande J, de Gast G, Bruning P
Neurology
. 2000 Jul;
55(1):117-9.
PMID: 10891918
Intraventricular chemotherapy with radiotherapy is the standard treatment of leptomeningeal metastasis (LM) from breast cancer; this treatment increases median survival only to about 3 months and is frequently complicated by...
5.
Sonnenschein E, Toniolo P, Terry M, Bruning P, Kato I, Koenig K, et al.
Int J Epidemiol
. 2000 Feb;
28(6):1026-31.
PMID: 10661643
Background: Excessive body weight is known to increase the risk of postmenopausal, but not premenopausal breast cancer. Some studies have suggested that being overweight is protective against premenopausal breast cancer,...
6.
Schagen S, van Dam F, Muller M, Boogerd W, Lindeboom J, Bruning P
Cancer
. 1999 Mar;
85(3):640-50.
PMID: 10091737
Background: A number of patients who have undergone adjuvant (CMF) chemotherapy for operative primary breast carcinoma have reported impaired cognitive function, sometimes even years after completion of therapy. The possible...
7.
Bruning P, Bonfrer J, Paridaens R, Nooij M, Klijn J, Beex L, et al.
Anticancer Drugs
. 1998 Jul;
9(5):419-25.
PMID: 9660539
The new non-steroidal aromatase inhibitor vorozole (R83842) was administered orally at a single daily dose of 2.5 mg to 27 postmenopausal women with advanced breast cancer in a phase II...
8.
Awada A, Van Vreckem A, Paridaens R, Bruning P, KLIJN J, Tomiak E, et al.
Eur J Cancer
. 1997 Jul;
33(8):1173-6.
PMID: 9301438
No abstract available.
9.
Zeleniuch-Jacquotte A, Bruning P, Bonfrer J, Koenig K, Shore R, Kim M, et al.
Am J Epidemiol
. 1997 Jun;
145(11):1030-8.
PMID: 9169912
The authors examined the relation between postmenopausal serum levels of testosterone and dehydroepiandrosterone sulfate (DHEAS) and subsequent risk of breast cancer in a case-control study nested within the New York...
10.
Maas R, Bruning P, Breedijk A, Peterse J
J Clin Pathol
. 1996 Jul;
49(7):607-9.
PMID: 8813968
The suitability of measuring the S-phase fraction in human breast cancer by labelling tumour cells from fine needle aspirates (FNAs) in vitro with iododeoxyuridine (IdU) was studied in 11 patients....